NVS - Novartis AG ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NVS is currently covered by 9 analysts with an average price target of $133.99. This is a potential upside of $16.02 (13.58%) from yesterday's end of day stock price of $117.97.

Novartis AG ADR's activity chart (see below) currently has 119 price targets and 97 ratings on display. The stock rating distribution of NVS is 57.14% HOLD, 33.33% BUY and 9.52% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.72% with an average time for these price targets to be met of 567.53 days.

Highest price target for NVS is $120, Lowest price target is $120, average price target is $104.02.

Most recent stock forecast was given by ETZER DAROUT from BMO on 30-Oct-2024. First documented stock forecast 15-Jan-2016.

Split History since 2000:

4/9/19 1116 for 1000

5/11/00 2 for 1

Currently out of the existing stock ratings of NVS, 12 are a HOLD (57.14%), 7 are a BUY (33.33%), 2 are a SELL (9.52%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$120

$5.75 (5.03%)

$118

8 months 24 days ago
(30-Oct-2024)

4/4 (100%)

$10.09 (9.18%)

139

Hold

$122.5

10 months 21 days ago
(03-Sep-2024)

8/8 (100%)

$16.06 (15.09%)

398

Hold

$95.34

1 years 3 months ago
(24-Apr-2024)

13/13 (100%)

$2.73 (2.95%)

580

$109

$-5.25 (-4.60%)

$114

1 years 5 months 8 days ago
(16-Feb-2024)

15/15 (100%)

$12.5 (12.95%)

892

Sell

$90.02

$-24.23 (-21.21%)

$100.71

1 years 9 months 1 days ago
(23-Oct-2023)

4/4 (100%)

$-1.19 (-1.30%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NVS (Novartis AG ADR) average time for price targets to be met?

On average it took 567.53 days on average for the stock forecasts to be realized with a an average price target met ratio 87.72

Which analyst has the current highest performing score on NVS (Novartis AG ADR) with a proven track record?

SEAMUS FERNANDEZ

Which analyst has the most public recommendations on NVS (Novartis AG ADR)?

Seamus Fernandez works at GUGGENHEIM and has 7 price targets and 5 ratings on NVS

Which analyst is the currently most bullish on NVS (Novartis AG ADR)?

Eric Le Berrigaud with highest potential upside - $21.14

Which analyst is the currently most reserved on NVS (Novartis AG ADR)?

Kerry Holford with lowest potential downside - -$36.12

Novartis AG ADR in the News

Novartis' Coartem Baby Gets Swissmedic Approval For Malaria In Newborn Babies, Young Infants

(RTTNews) – Novartis Pharma AG, affiliated to Swiss drug major Novartis AG (NVS), announced Tuesday that Coartem (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The company added that eight African countries also participated in the assessment and are now expected to issue rapid approvals under...

Novartis receives approval for first malaria medicine for newborn babies and young infants

Novartis Pharma AG CoartemĀ® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global health scheme run by Swiss agency for therapeutic products (Swissmedic) Novartis plans to introduce infant-friendly Coartem Baby on largely not-for-profit basis to increase access in areas...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?